Also found in: Medical.
IRBPInterphotoreceptor Retinoid-Binding Protein
IRBPInterstitial Retinol-Binding Protein
IRBPInvestor Relations Best Practice (Investor Relations Society; award; UK)
IRBPImidazoline Receptor Binding Protein
IRBPIntercellular Retinoid Binding Protein (cell biology)
IRBPImmunoreactive Retinol-Binding Protein (endocrinology)
References in periodicals archive ?
IRBP met with the Seppic executives & Seppic has agreed to donate the IFA adjuvant for the commercial manufacturing of Remune HIV/AIDS vaccine.
IRBP has voluntarily agreed to an FDA black box warning label for Remune to be used in conjunction with current FDA approved HAART drugs.
The allele sizes for each locus were: OBCAM 189, 195; KCSN 190, 192; IGF-1 110, 112; CRFA 253, 255; IRBP 141 (or 177), 143 (or 179), 145 (or 181) (Table 1).
obs] was for the IRBP locus between the Cote-Nord and Zecs populations (P = 0.
Hollyfield at Baylor College of Medicine in Houston, who tracked retinoid flow between artificial cell membranes in solutions with and without IRBP.
IRBP notified the FDA that Remune will likely be available only in the U.
initially as IRBP does not anticipate being able to manufacture enough vaccine as it would be unfair to the U.
IRBP is committed to manufacturing the Remune vaccine & the required three commercial lot batches to secure marketing authorization in the U.
IRBP estimates a minimum of 18 months to manufacture new vaccine once manufacturing begins with a time frame of 18-24 months before vaccine is available.
Part I of the project entails laying of 61 km of 20 inch diameter loopline between Shaikarpur and Larkana in order to be able to pig and clean the 18 inch IRBP in segments.
I thank the FDA for coming around on Remune, I applaude the agency for getting serious about helping give people with HIV an alternative to toxic drugs, hopefully it goes up for a quick vote in the fall to help the public with this awful disease," IRBP CEO Mr.
IRBP Announced Plans for a New Pediatric Remune Phase II Study & FDA Breakthrough Designation Application IND to be filed with FDA